⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LYEL News
Lyell Immunopharma, Inc. Common Stock
Form 8-K
sec.gov
LYEL
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
globenewswire.com
LYEL
Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion
globenewswire.com
LYEL
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
globenewswire.com
LYEL
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
globenewswire.com
LYEL
Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
globenewswire.com
AGEN
EXEL
ABBV
BMY
MRK
LYEL
PFE
BNTX
NVDA
IBM
GEHC
ABT
QGEN
TMO
DHR
MYGN
ILMN
EXAS
INV
Lyell Immunopharma Announces Participation in May Investor Conferences
globenewswire.com
LYEL
Form 8-K
sec.gov
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
globenewswire.com
LYEL
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
LYEL